series-b
Stage
3
Investors
About
Mirador Therapeutics is a clinical-stage precision medicine company focused on developing first-in-class or best-in-class therapeutics for immune-mediated inflammatory and fibrotic diseases. It utilizes its proprietary Mirador360™ precision development engine, which leverages advances in human genetics, multi-modal data, and AI to accelerate the discovery and development of novel therapies.
Explore Mirador Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.